Agfa HealthCare to highlight IMPAX Cardiovascular IT solutions at EuroPCR

Agfa HealthCare announces today that it will highlight its comprehensive IMPAX Cardiovascular suite of products at the EuroPCR congress, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), from May 21-24, in Paris, France. The focus will be on demonstrating how IMPAX Cardiovascular delivers the benefits of digital cardiology to the cardiologist's fingertips.

Single point of access to cardiology tools and data

Standards-based and vendor-neutral, the IMPAX Cardiovascular suite offers true structured reporting capabilities and clinical decision support, and consolidates each patient's relevant cardiology procedure information. This provides clinicians with a single point of access offering a toolkit that supports a diagnostic workflow, and provides secure, anytime, anywhere management of the patient's record with fast access to cardiology information.

Optimized workflow and enhanced ease of use

Tools to be highlighted at EuroPCR this year focus on optimizing workflow and enhancing ease of use, and provide in-depth procedure-oriented clinical content, while sharing a common platform with the rest of the clinical procedures. They include comprehensive and intuitive structured reporting for diagnostic, PCI and TAVI procedures, multimodality review and analysis, automated Syntax and EuroScore calculation and built-in registry support.

Other specialist features for cardiologists include one-click front-end image-data integration, clinical workflow integration from report elaboration to report distribution, and a unified clinical back-end for research data, completing the consolidation of images and data across the wide range of cardiology sub-specialties.

Please visit booth #M35 for a demonstration or to speak with an Agfa HealthCare product expert.

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions.  The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's.  Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.  For more information on Agfa HealthCare, please visit www.agfahealthcare.com

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.